Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.95 GBX | +0.77% | +0.99% | +13.46% |
09-30 | EARNINGS: Alliance Pharma swings to profit; DG Innovate loss widens | AN |
09-30 | Alliance Pharma plc Provides Revenue Guidance for the Full Year 2024 | CI |
Capitalization | 248M 316M 299M 278M 442M 26.69B 485M 3.45B 1.28B 10.95B 1.19B 1.16B 47.49B | P/E ratio 2024 * |
16x | P/E ratio 2025 * | 12.3x |
---|---|---|---|---|---|
Enterprise value | 322M 409M 388M 361M 573M 34.6B 628M 4.47B 1.66B 14.2B 1.54B 1.5B 61.58B | EV / Sales 2024 * |
1.7x | EV / Sales 2025 * | 1.48x |
Free-Float |
88.05% | Yield 2024 * |
0.57% | Yield 2025 * | 0.6% |
Last Transcript: Alliance Pharma plc
1 day | +0.77% | ||
1 week | +0.99% | ||
1 month | +2.68% | ||
3 months | +25.20% | ||
6 months | +18.43% | ||
Current year | +13.46% |
Director | Title | Age | Since |
---|---|---|---|
Andrew Franklin
DFI | Director of Finance/CFO | 58 | 27/09/2015 |
Julie Skinner
HRO | Human Resources Officer | - | 31/10/2023 |
General Counsel | - | 31/12/2016 |
Manager | Title | Age | Since |
---|---|---|---|
Andrew Franklin
BRD | Director/Board Member | 58 | 27/09/2015 |
Richard Jones
BRD | Director/Board Member | 58 | 31/12/2018 |
Director/Board Member | 46 | 30/11/2021 |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+0.77% | +0.99% | +18.58% | -54.86% | 316M | ||
+2.69% | -0.80% | +45.28% | +136.32% | 50.52B | ||
-0.03% | -2.53% | +52.66% | +109.48% | 31.09B | ||
-0.32% | -1.13% | +60.50% | - | 19.97B | ||
+2.76% | +3.19% | +26.53% | +57.92% | 14.65B | ||
+1.82% | +1.78% | +51.51% | +107.62% | 11.49B | ||
-.--% | +0.14% | - | - | 6.79B | ||
-.--% | -1.95% | - | - | 5.73B | ||
+0.38% | -0.89% | -36.35% | -30.87% | 5.41B | ||
+0.96% | +9.68% | +3.76% | +23.14% | 5.36B | ||
Average | +0.90% | +0.80% | +27.81% | +49.82% | 15.13B | |
Weighted average by Cap. | +1.30% | -0.26% | +42.82% | +103.64% |
2024 * | 2025 * | |
---|---|---|
Net sales | 189M 240M 228M 212M 336M 20.31B 369M 2.62B 976M 8.33B 902M 882M 36.14B | 200M 254M 241M 224M 356M 21.51B 391M 2.78B 1.03B 8.83B 956M 934M 38.28B |
Net income | 15.56M 19.76M 18.73M 17.43M 27.69M 1.67B 30.35M 216M 80.34M 686M 74.25M 72.6M 2.97B | 20.35M 25.85M 24.5M 22.8M 36.22M 2.19B 39.7M 282M 105M 897M 97.13M 94.97M 3.89B |
Net Debt | 73.66M 93.58M 88.7M 82.52M 131M 7.91B 144M 1.02B 380M 3.25B 352M 344M 14.08B | 48.51M 61.64M 58.42M 54.35M 86.35M 5.21B 94.64M 673M 251M 2.14B 232M 226M 9.28B |
Date | Price | Change | Volume |
---|---|---|---|
29/11/24 | 45.95 p | +0.77% | 565,913 |
28/11/24 | 45.60 p | +1.11% | 1,527,702 |
27/11/24 | 45.10 p | +0.11% | 472,458 |
26/11/24 | 45.05 p | -0.66% | 473,782 |
25/11/24 | 45.35 p | -0.33% | 659,139 |
Delayed Quote London S.E., November 29, 2024 at 04:35 pm
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- APH Stock
MarketScreener is also available in this country: United States.
Switch edition